{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T15:02:10Z","timestamp":1780498930360,"version":"3.54.1"},"reference-count":17,"publisher":"Japanese Society of Internal Medicine","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2014]]},"DOI":"10.2169\/internalmedicine.53.1458","type":"journal-article","created":{"date-parts":[[2014,2,28]],"date-time":"2014-02-28T23:13:20Z","timestamp":1393629200000},"page":"375-381","source":"Crossref","is-referenced-by-count":4,"title":["Immunochemical Fecal Occult Blood Tests Predict Dual Antiplatelet Therapy Discontinuation after Coronary Stenting"],"prefix":"10.2169","volume":"53","author":[{"given":"Ken","family":"Ikeda","sequence":"first","affiliation":[{"name":"Department of Cardiovascular and Respiratory Medicine, Akita University Graduate School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Koyama","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular and Respiratory Medicine, Akita University Graduate School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaru","family":"Ishida","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular and Respiratory Medicine, Akita University Graduate School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Megumi","family":"Okawa","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular and Respiratory Medicine, Akita University Graduate School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasunori","family":"Oguma","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular and Respiratory Medicine, Akita University Graduate School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yutaka","family":"Terata","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular and Respiratory Medicine, Akita University Graduate School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenji","family":"Iino","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular and Respiratory Medicine, Akita University Graduate School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshimitsu","family":"Kosaka","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular and Respiratory Medicine, Akita University Graduate School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroyuki","family":"Watanabe","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular and Respiratory Medicine, Akita University Graduate School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Ito","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular and Respiratory Medicine, Akita University Graduate School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Iakovou I, Schmidt T, Bonizzoni E, et al. Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents. JAMA 293: 2126-2130, 2005.","DOI":"10.1001\/jama.293.17.2126"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Park DW, Park SW, Park KH, et al. Frequency of and risk factors for stent thrombosis after drug-eluting stent implantation during long-term follow-up. Am J Cardiol 98: 352-356, 2006.","DOI":"10.1016\/j.amjcard.2006.02.039"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Kimura T, Morimoto T, Nakagawa Y, et al. Antiplatelet therapy and stent thrombosis after sirolimus-eluting stent implantation. Circulation 119: 987-995, 2009.","DOI":"10.1161\/CIRCULATIONAHA.108.808311"},{"key":"4","unstructured":"4. King SB 3rd, Smith SC Jr, Hirshfeld JW Jr, et al. 2007 Focused Update of the ACC\/AHA\/SCAI 2005 Guideline Update for Percutaneous Coronary Intervention: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines: 2007 Writing Group to Review New Evidence and Update the ACC\/AHA\/SCAI 2005 Guideline Update for Percutaneous Coronary Intervention, Writing on Behalf of the 2005 Writing Committee. Circulation 117: 261-295, 2008."},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Wijns W, Kolh P, Danchin N, et al. Guidelines on myocardial revascularization. Eur Heart J 31: 2501-2555, 2010.","DOI":"10.1093\/eurheartj\/ehq172"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Rossini R, Capodanno D, Lettieri C, et al. Prevalence, predictors, and long-term prognosis of premature discontinuation of oral antiplatelet therapy after drug eluting stent implantation. Am J Cardiol 107: 186-194, 2011.","DOI":"10.1016\/j.amjcard.2010.08.067"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Ishida M, Watanabe H, Iino K, Okawa M, Kosaka T, Ito H. Low mean corpuscular hemoglobin level is a predictor of discontinuation of antiplatelet therapy in patients with acute coronary syndrome. Intern Med 50: 2933-2939, 2011.","DOI":"10.2169\/internalmedicine.50.6081"},{"key":"8","unstructured":"8. Berger PB, Bhatt DL, Fuster V, et al. Bleeding complications with dual antiplatelet therapy among patients with stable vascular disease or risk factors for vascular disease: results from the Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management, and Avoidance (CHARISMA) trial. Circulation 121: 2575-2583, 2010."},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Ferreira-Gonzalez I, Marsal JR, Ribera A, et al. Background, incidence, and predictors of antiplatelet therapy discontinuation during the first year after drug-eluting stent implantation. Circulation 122: 1017-1025, 2010.","DOI":"10.1161\/CIRCULATIONAHA.110.938290"},{"key":"10","unstructured":"10. Casado Arroyo R, Polo-Tomas M, Roncales MP, Scheiman J, Lanas A. Lower GI bleeding is more common than upper among patients on dual antiplatelet therapy: long-term follow-up of a cohort of patients commonly using PPI co-therapy. Heart 98: 718-723, 2012."},{"key":"11","unstructured":"11. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 130: 461-470, 1999."},{"key":"12","unstructured":"12. Wiviott SD, Antman EM, Gibson CM, et al. Evaluation of prasugrel compared with clopidogrel in patients with acute coronary syndromes: design and rationale for the TRial to assess Improvement in Therapeutic Outcomes by optimizing platelet InhibitioN with prasugrel Thrombolysis In Myocardial Infarction 38 (TRITON-TIMI 38). Am Heart J 152: 627-635, 2006."},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Brenner H, Tao S, Haug U. Low-dose aspirin use and performance of immunochemical fecal occult blood tests. JAMA 304: 2513-2520, 2010.","DOI":"10.1001\/jama.2010.1773"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Yang SY, Kim YS, Chung SJ, et al. Association between colorectal adenoma and coronary atherosclerosis detected by CT coronary angiography in Korean men; a cross-sectional study. J Gastroenterol Hepatol 25: 1795-1799, 2010.","DOI":"10.1111\/j.1440-1746.2010.06330.x"},{"key":"15","unstructured":"15. Valgimigli M, Campo G, Monti M, et al. Short- versus long-term duration of dual-antiplatelet therapy after coronary stenting: a randomized multicenter trial. Circulation 125: 2015-2026, 2012."},{"key":"16","unstructured":"16. Kim BK, Hong MK, Shin DH, et al. A New Strategy for Discontinuation of Dual Antiplatelet Therapy: The RESET Trial (REal Safety and Efficacy of 3-month dual antiplatelet Therapy following Endeavor zotarolimus-eluting stent implantation). J Am Coll Cardiol 60: 1340-1348, 2012."},{"key":"17","unstructured":"17. Gwon HC, Hahn JY, Park KW, et al. Six-month versus 12-month dual antiplatelet therapy after implantation of drug-eluting stents: the Efficacy of Xience\/Promus Versus Cypher to Reduce Late Loss After Stenting (EXCELLENT) randomized, multicenter study. Circulation 125: 505-513, 2012."}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/53\/5\/53_53.1458\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,28]],"date-time":"2022-03-28T02:34:09Z","timestamp":1648434849000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/53\/5\/53_53.1458\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014]]},"references-count":17,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2014]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.53.1458","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014]]}}}